| Loss of TP63 promotes the metastasis of head and neck squamous cell carcinoma by activating MAPK and STAT3 signaling S Lakshmanachetty, V Balaiya, WA High, MI Koster Molecular Cancer Research 17 (6), 1279-1293, 2019 | 33 | 2019 |
| New insights into the multifaceted role of myeloid-derived suppressor cells (MDSCs) in high-grade gliomas: from metabolic reprograming, immunosuppression, and therapeutic … S Lakshmanachetty, J Cruz-Cruz, E Hoffmeyer, AP Cole, SS Mitra Cells 10 (4), 893, 2021 | 29 | 2021 |
| Microglia in the brain tumor microenvironment AP Cole, E Hoffmeyer, SL Chetty, J Cruz-Cruz, F Hamrick, O Youssef, ... Tumor Microenvironment: Hematopoietic Cells–Part B, 197-208, 2020 | 18 | 2020 |
| AT cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice W Li, AK Murthy, GK Lanka, SL Chetty, JJ Yu, JP Chambers, G Zhong, ... Vaccine 31 (48), 5722-5728, 2013 | 15 | 2013 |
| Francisella DnaK inhibits tissue-nonspecific alkaline phosphatase BP Arulanandam, SL Chetty, JJ Yu, S Leonard, K Klose, J Seshu, A Cap, ... Journal of Biological Chemistry 287 (44), 37185-37194, 2012 | 9 | 2012 |
| Venetoclax cooperates with ionizing radiation to attenuate diffuse midline glioma tumor growth K Madhavan, I Balakrishnan, S Lakshmanachetty, A Pierce, B Sanford, ... Clinical Cancer Research 28 (11), 2409-2424, 2022 | 8 | 2022 |
| Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumors I Alimova, D Wang, E Danis, A Pierce, A Donson, N Serkova, K Madhavan, ... International Journal of Oncology 60 (3), 1-14, 2022 | 7 | 2022 |
| TRP63/TP63 loss accelerates skin tumorigenesis through activation of Wnt/β-catenin signaling S Lakshmanachetty, V Balaiya, LK Johnson, MI Koster Journal of dermatological science 91 (3), 325-328, 2018 | 7 | 2018 |
| Mapping the tumor-infiltrating immune cells during glioblastoma progression S Lakshmanachetty, SS Mitra Nature immunology 23 (6), 826-828, 2022 | 5 | 2022 |
| A human stem cell-based system to study the role of TP63 mutations in ectodermal dysplasias JD Dinella, J Chen, S Webb, E Siegfried, AF Bree, S Lakshmanachetty, ... The Journal of investigative dermatology 138 (7), 1662, 2018 | 5 | 2018 |
| Emerging roles for collagen XV and XVIII in cancer progression. S Lakshmanachetty, MI Koster Experimental dermatology 25 (5), 2016 | 5 | 2016 |
| Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens DW Kwok, NO Stevers, T Nejo, LH Chen, I Etxeberria, J Jung, K Okada, ... bioRxiv, 2023.10. 19.563178, 2023 | 3 | 2023 |
| Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma M Gallus, D Kwok, S Lakshmanachetty, A Yamamichi, H Okada Cancers 15 (14), 3726, 2023 | 2 | 2023 |
| Glioma-neuronal circuit remodeling induces regional immunosuppression T Nejo, S Krishna, C Jimenez, A Yamamichi, JS Young, ... bioRxiv, 2023.08. 04.548295, 2023 | 2 | 2023 |
| Glioma-induced neuronal remodeling promotes regional immunosuppression T Nejo, S Krishna, C Jimenez, A Yamamichi, JS Young, T Chen, ... Cancer Research 83 (7_Supplement), 2497-2497, 2023 | 1 | 2023 |
| Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types D Kwok, NO Stevers, T Nejo, LH Chen, I Etxeberria, J Jung, K Okada, ... Cancer Research 84 (6_Supplement), 3907-3907, 2024 | | 2024 |
| Low-intensity pulsed ultrasound enhances the presentation of brain-derived antigens by facilitating the migration of antigen-presenting cells from the brain to the periphery M Gallus, VA Arrieta, A Saijo, P Chuntova, A Yamamichi, J Haegelin, ... Cancer Research 84 (6_Supplement), 6648-6648, 2024 | | 2024 |
| Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma T Nejo, L Wang, KK Leung, A Wang, S Lakshmanachetty, M Gallus, ... Scientific Reports 14 (1), 6362, 2024 | | 2024 |
| Targeting Diffuse Midline Glioma with a novel anti-CD99 Antibody I Balakrishnan, K Madhavan, AM Pierce, JA Michlin, B Brunt, SL Chetty, ... bioRxiv, 2024.03. 19.585814, 2024 | | 2024 |
| Gallus et al. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma.(vol 15, 3726, 2023) M Gallus, D Kwok, S Lakshmanachetty, A Yamamichi, H Okada CANCERS 16 (1), 2024 | | 2024 |
